108 related articles for article (PubMed ID: 12587836)
1. Role of allergy in the therapeutic response of nasal polyps.
Kirtsreesakul V
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):141-6. PubMed ID: 12587836
[TBL] [Abstract][Full Text] [Related]
2. Nasal polyposis: role of allergy on therapeutic response of eosinophil- and noneosinophil-dominated inflammation.
Kirtsreesakul V; Atchariyasathian V
Am J Rhinol; 2006; 20(1):95-100. PubMed ID: 16539303
[TBL] [Abstract][Full Text] [Related]
3. Nasal polyps: the relationship to allergy, sinonasal infection and histopathological type.
Kirtsreesakul V
J Med Assoc Thai; 2004 Mar; 87(3):277-82. PubMed ID: 15117044
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment.
Lildholdt T; Rundcrantz H; Bende M; Larsen K
Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):595-600. PubMed ID: 9193219
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps.
Jankowski R; Schrewelius C; Bonfils P; Saban Y; Gilain L; Prades JM; Strunski V
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):447-52. PubMed ID: 11296057
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of a short course of systemic steroids in nasal polyposis.
Kirtsreesakul V; Wongsritrang K; Ruttanaphol S
Rhinology; 2011 Dec; 49(5):525-32. PubMed ID: 22125782
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide.
Lildholdt T; Rundcrantz H; Lindqvist N
Clin Otolaryngol Allied Sci; 1995 Feb; 20(1):26-30. PubMed ID: 7788929
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of topical corticosteroid for the clinical treatment of nasal polyposis: searching for clinical events that may predict response to treatment.
Valera FC; Anselmo-Lima WT
Rhinology; 2007 Mar; 45(1):59-62. PubMed ID: 17432072
[TBL] [Abstract][Full Text] [Related]
9. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps.
Vendelo Johansen L; Illum P; Kristensen S; Winther L; Vang Petersen S; Synnerstad B
Clin Otolaryngol Allied Sci; 1993 Dec; 18(6):524-7. PubMed ID: 8877234
[TBL] [Abstract][Full Text] [Related]
10. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in chronic rhinosinusitis with nasal polyps].
Wang C; Lou H; Lou W; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):347-50. PubMed ID: 22730816
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps.
Tos M; Svendstrup F; Arndal H; Orntoft S; Jakobsen J; Borum P; Schrewelius C; Larsen PL; Clement F; Barfoed C; Rømeling F; Tvermosegaard T
Am J Rhinol; 1998; 12(3):183-9. PubMed ID: 9653476
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide).
Johansson L; Holmberg K; Melén I; Stierna P; Bende M
Acta Otolaryngol; 2002 Jan; 122(1):49-53. PubMed ID: 11876598
[TBL] [Abstract][Full Text] [Related]
14. Does oral prednisolone increase the efficacy of subsequent nasal steroids in treating nasal polyposis?
Kirtsreesakul V; Wongsritrang K; Ruttanaphol S
Am J Rhinol Allergy; 2012; 26(6):455-62. PubMed ID: 23232195
[TBL] [Abstract][Full Text] [Related]
15. [Effects of intranasal budesonide on the infiltration and activation of eosinophils in nasal polyps].
Zhang L; Han D; Zhang Y; Zhou B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):129-32. PubMed ID: 12768671
[TBL] [Abstract][Full Text] [Related]
16. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
[TBL] [Abstract][Full Text] [Related]
17. Role of allergy in nasal polyps of Thai patients.
Pumhirun P; Limitlaohapanth C; Wasuwat P
Asian Pac J Allergy Immunol; 1999 Mar; 17(1):13-5. PubMed ID: 10403004
[TBL] [Abstract][Full Text] [Related]
18. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
Tingsgaard PK; Bock T; Larsen PL; Tos M
Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids.
Kim YK; Uno M; Hamilos DL; Beck L; Bochner B; Schleimer R; Denburg JA
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):388-97. PubMed ID: 10030836
[TBL] [Abstract][Full Text] [Related]
20. Agreement rate of skin prick test with tissue eosinophil count in patients with nasal polyps.
Eghtedari F; Cheraghzadeh SR; Kashef MA; Monabati A; Kashef S
Iran J Allergy Asthma Immunol; 2007 Jun; 6(2):89-92. PubMed ID: 17563409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
